Perez, Rhandel G.
HRN: 25-34-32 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2024
CEFUROXIME 750MG (VIAL)
06/21/2024
06/28/2024
IV
750mg
Q8H
Paraphimosis
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes